Related references
Note: Only part of the references are listed.Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia
Etsuko Yamazaki et al.
LEUKEMIA & LYMPHOMA (2017)
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups
Marlise R. Luskin et al.
BLOOD (2016)
Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study)
Julie-Anne Nazare et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT
S. Fuji et al.
BONE MARROW TRANSPLANTATION (2014)
Quantitative relationship between body weight gain in adulthood and incident type 2 diabetes: a meta-analysis
S. Kodama et al.
OBESITY REVIEWS (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Obesity as a Major Risk Factor for Cancer
Giovanni De Pergola et al.
JOURNAL OF OBESITY (2013)
Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
Mikkel Krogh-Madsen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia
Bruno C. Medeiros et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Jennifer J. Griggs et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study
Shigeki Ohtake et al.
BLOOD (2011)
A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study
Shuichi Miyawaki et al.
BLOOD (2011)
Drug disposition in obesity and protein-energy malnutrition
Joseph I. Boullata
PROCEEDINGS OF THE NUTRITION SOCIETY (2010)
Mortality, Health Outcomes, and Body Mass Index in the Overweight Range A Science Advisory From the American Heart Association
Cora E. Lewis et al.
CIRCULATION (2009)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Drug therapy - Drug metabolism and variability among patients in drug response
GR Wilkinson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mortality in overweight and children with acute myeloid underweight leukemia
BJ Lange et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Criteria and classification of obesity in Japan and Asia-Oceania
M Kanazawa et al.
ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION (2002)
Criteria and classification of obesity in Japan and Asia-Oceania
M Kanazawa et al.
ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION (2002)
Criteria and classification of obesity in Japan and Asia-Oceania
M Kanazawa et al.
ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION (2002)
Share Paper
